Godrej Agrovet Ltd (GODREJAGRO) Q1 FY27 Results Analysis: PAT Falls 14%, PBT Misses Guidance
Godrej Agrovet Ltd's Q1 FY27 numbers came in soft, with revenue of Rs. 2,855.22 Cr (+9.22% YoY) and PAT growth of -13.79% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | August 05, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Revenue (Q1) | Rs. 2,855.22 Cr (+9.22% YoY) |
| PAT (Q1) | Rs. 128.31 Cr (-13.79% YoY) |
| EBITDA margin | 8.93% (-184 bps YoY) |
| EPS (Q1) | Rs. 6.99 (-16.29% YoY) |
| Market cap | Rs. 10,899.14 Cr |
| CMP | Rs. 566.45 |
Quarter Snapshot
Q1 FY27 revenue grew 9.2% YoY to Rs.2,855.22 cr, but PAT fell 13.8% YoY to Rs.128.31 cr as input costs rose faster than revenue. EBITDA margin compressed 184 bps to 8.93% and Q1 PBT missed management's mid-teens growth guidance; Animal Nutrition and Oil Palm were strong while Crop Care, Dairy, and Poultry dragged. Management expects Crop Care recovery from Q2 and revenue remains on track for early double-digit FY27 growth.
Key Investment Insights
Key Positives
- Animal Nutrition PBIT rose 29.7% YoY to Rs.83.68 cr, with segment margin up 85 bps to 6.43%.
- Vegetable Oil segment revenue rose 24.1% YoY to Rs.619.24 cr and PBIT rose 14.7% to Rs.99.61 cr.
- Gross debt-equity improved from 0.95 to 0.71 YoY; net worth rose 12.2% to Rs.2,294.64 cr.
- Finance costs fell 16.1% YoY to Rs.29.79 cr.
- Interest service coverage improved to 6.66x from 6.30x.
Risk Factors
- Consolidated PAT fell 13.8% YoY to Rs.128.31 cr; PAT attributable to owners fell 16.2% to Rs.134.50 cr.
- EBITDA margin compressed 184 bps YoY to 8.93%, with cost of materials up 17.7% versus revenue up 9.2%.
- Crop Care revenue fell 13.3% and PBIT fell 35.1%; Dairy swung to a Rs.1.90 cr PBIT loss; Poultry PBIT fell 80.5%.
- Effective tax rate rose 339 bps YoY to 29.16%, partly from Section 115BAA deferred tax recognition at Godrej Foods.
- Q1 PBT of Rs.168.50 cr was 10.46% below year-ago, missing management's mid-teens PBT growth guidance.
Ask about this
Ask Cofacto a question about this result. Answers cite filings and company data.
Related
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.